Advisory Board

Advisory Board

David Jolly

David Jolly serves as general counsel for Novo Biosciences. Mr. Jolly is a former U.S. congressman and business development and communications expert. He practiced securities law at Fried, Frank, Harris, Shriver & Jacobson, served as general counsel to United States Representative C. W. Bill Young, and served as a vice president at Van Scoyoc Associates, a government affairs firm in Washington D.C. Mr. Jolly has owned and operated his own law firm, government affairs firm, and communications firm and serves on several corporate boards, including both private and publicly held companies. He received his B.A. from Emory University in History and a J.D., cum laude, from George Mason University. Mr. Jolly is currently Executive Vice President & Principal of Shumaker Advisors Florida, where he provides communications strategy and business development services throughout the nation to companies and non-profit organizations.

Dr. Richard T. Lee, M.D.

Dr. Richard T. Lee, M.D., is Professor of Stem Cell and Regenerative Biology at Harvard University and Professor of Medicine at Harvard Medical School. His research focuses on developing new approaches for treating cardiovascular and metabolic diseases using genomics, stem cell biology, and molecular biology. Ongoing research projects in Dr. Lee’s laboratory include studies of cardiac regeneration, diabetes, aging and metabolism. Dr. Lee has published over 200 peer-reviewed articles based on his research and teaches undergraduates at Harvard College.

Dr. Lee is a 1979 graduate of Harvard College in Biochemical Sciences and received his M.D. from Cornell University Medical College in 1983. He completed his residency in 1986 and cardiology fellowship in 1989, both at Brigham and Women’s Hospital in Boston. Dr. Lee is certified by the American Board of Internal Medicine in cardiovascular disease and is a Fellow of the American College of Cardiology. He is Leader of the Cardiovascular Program of the Harvard Stem Cell Institute. Dr. Lee is an active clinician and regularly treats patients as a cardiologist at Brigham and Women’s Hospital.

Dr. Lee is co-founder of Elevian, Inc. and ProteoThera, Inc. Both companies focus on the development of regenerative medicine therapies to treat age-related and autoinflammatory diseases. Dr. Lee is the recipient of the NIH Director’s Transformative Research Award, given for interdisciplinary research that has the potential to change paradigms.

Dr. Thomas Rando, M.D., Ph.D.

Dr. Thomas Rando, M.D., Ph.D., received his AB, M.D., and Ph.D. degrees from Harvard University and then completed a residency in neurology at UCSF and postdoctoral training at Stanford University. He is currently Professor of Neurology and Neurological Sciences and Director of the Glenn Center for the Biology of Aging at Stanford University School of Medicine. Dr. Rando directs the Center for Tissue Regeneration, Repair, and Restoration (CTR3), a program in regenerative medicine combining expertise in stem cell biology and bioengineering, at the VA Palo Alto Health Care System where he is also Chief of Neurology. Dr. Rando was also the founding director of the Muscular Dystrophy Association clinic at Stanford.

Dr. Rando’s research focuses on stem cell biology, with particular interests in stem cell aging and stem cell therapeutics. He has pioneered the field of systemic factors as regulators of cellular aging based upon seminal studies done in his laboratory using the technique of heterochronic parabiosis. These studies have formed the foundation of current approaches to epigenetic rejuvenation. His laboratory has also pioneered studies using muscle stem cells to replace or restore functional muscle in preclinical studies of trauma and degenerative diseases such as the muscular dystrophies, with broad implications for the field of regenerative medicine.

Dr. Rando has received numerous awards including the NIH Director’s Pioneer Award, the “Breakthroughs in Gerontology” Award from the American Federation for Aging Research, and a Transformative Research Award from the NIH. Dr. Rando is a member of the National Academy of Medicine and a Fellow of the American Association for the Advancement of Science.